Study Details
Full Title
A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of AZD5305 in Combination with Physician's Choice New Hormonal Agents in Patients with HRRm and non-HRRm Metastatic Castration-Sensitive Prostate Cancer (EvoPAR-Prostate01)
Principal Investigator
Jeffrey
Shevach
Protocol Number
PRO00114544
NCT ID
NCT06120491
Phase
III
Enrollment Status
Open to Enrollment